Citations

Showing 10 of 107868 citations.

Molecular Regulation of Cardiomyocyte Cell Cycle and Regeneration
Li, Fan , Son, Yura , Yang, Ming , Zhu, Wuqiang, Yang, Ming , Zhu, Wuqiang , Li, Faqin , Zhu, Wuqiang , Son, Yura

Mayo Clinic

Biology | April 2, 2026 | Volume: 15 | Issue: 7 | Pages: 568

10.3390/biology15070568 | PMID 41972571 Get It

The regulation of the cardiomyocyte cell cycle is central to understanding heart regeneration. In adult mammals, cardiomyocytes withdraw from the cell cycle, limiting their ability to proliferate and repair heart tissue after injury. This process is controlled by intrinsic genetic programs and extrinsic signals, which together restrict the regenerative response in mature hearts. Understanding the mechanisms that regulate cardiomyocyte cell cycle activity is therefore critical for advancing cardiac regenerative medicine. In this review, we provide a comparative and integrated overview of cardiomyocyte cell cycle regulation in lower vertebrates and mammals, and discuss the major intrinsic factors that govern this process, including cyclin/CDK pathways, transcription factors and co-activators, oxygen and metabolic regulation, and epigenetic mechanisms. We also review the influence of hormones and growth factors, as well as the supportive roles of nonmyocyte populations in heart regeneration. By integrating findings across species, developmental stages, and regulatory levels, these findings highlight the complex regulatory network controlling cardiomyocyte proliferation and provide insight into potential therapeutic strategies for stimulating cardiac repair in the adult mammalian heart.
Estimating Blood Volume Loss With Wireless, Wearable Ultrasound: A Pilot Investigation
Kenny, Jon‐Émile S. , Savery, Tracy, Lachner-Piza, Daniel, Eibl, Andrew M., Eibl, Joseph K. , Vungarala, Soumya , Dietz, Niki M., Kim, Chul-Ho, Johnson, Bruce D, Hebscher, Melissa , Atwi, Sarah , Piza, Daniel Lachner , Johnson, Bruce D.

Mayo Clinic

Military Medicine | April 2, 2026 | Volume: 191 | Issue: Supplement_1 | Pages: 386-392

10.1093/milmed/usag109 | PMID 42560273 Get It

Abstract Introduction Detecting and estimating blood volume loss are important for the diagnosis and management of life-threatening hemorrhage. There is a direct relationship between percent blood volume loss (BVL%) and falling in stroke volume (SV); furthermore, there is a direct relationship between diminishing SV and the corrected flow time of the carotid artery (ccFT). Therefore, we hypothesized that change in ccFT (ccFTΔ) would directly relate with BVL% in a phlebotomy paradigm. Materials and Methods A prospective, convenience sample of healthy volunteers was studied. Volunteers underwent blood donation protocol in a physiology lab. A wireless, wearable Doppler ultrasound system monitored ccFT during blood donation. Traditional vital signs were also measured throughout. The relationship between traditional vital signs as well as ccFTΔ were compared to BVL% using 2 mixed linear regression models. Results Data from 20 subjects and blood donations comprising 46,123 cardiac cycles are included. On average 413.5 ± 39 mL of blood were drawn representing 8.6 ± 1.6% BVL%. There was a significant and strong linear relationship between BVL% and ccFTΔ during blood draw with the regression slope demonstrating that for every 1 ms reduction in ccFT there was a 0.4% reduction in blood volume. Conclusions In healthy subjects and when blood loss is the sole mechanism for falling SV, we estimate that for every 1 ms reduction in ccFT, there is an approximate 0.4 BVL%. Validation of these results in patients with traumatic hemorrhage is underway.
Optimizing Retrieval-Augmented Generation (RAG) in clinical medicine: methods and performance evaluation
Li, Pengze, Patel, Anshum , Vallamchetla, Sai Krishna , Heninger, Hayden, Contractor, Het, Tao, Cui, Cheung, Joseph, Cheung, Joseph , Cheung, Joseph , Li, Pengze, Tao, Cui

Mayo Clinic

Journal of the American Medical Informatics Association | April 2, 2026 | Volume: 33 | Issue: 8 | Pages: 1436-1445

10.1093/jamia/ocag056 | PMID 42243630 Get It

Abstract Objective Evaluate how RAG architecture, including corpus structure, retrieval strategy, and pipeline complexity, affects LLM-based medical problem solving and knowledge retrieval in sleep medicine. Materials and Methods We benchmarked four open-source LLMs (Llama-3-8B, Llama -3 -70B, Qwen 2.5-14B, and Qwen 2.5-235B) using a knowledge base of five sleep medicine textbooks. We compared performance across three dimensions: corpus structure (raw text vs table-of-contents aligned.), retrieval strategy (dense embedding vs hybrid sparse-dense), and pipeline complexity (baseline vs augmented). Evaluation metrics included board-style multiple choice question (MCQ) accuracy and clinical case vignette diagnostic ranking. Results RAG improved MCQ accuracy for all models. Llama-8B saw the largest gain of 10.6% (61.8% to 72.4%), while Qwen-235B reached 87.3%. In clinical cases, Llama-8B accuracy dropped by 7.1% when using raw text and dense retrieval due to context noise. This was corrected by using structured hybrid configurations. Hybrid retrieval consistently outperformed dense-only methods. Overall, structured corpora improved primary diagnosis accuracy by 6.1% on average, with Qwen-235B reaching a peak 10.2% increase. Discussion RAG effectiveness depends on the balance between model size and data structure. Large models handle uncurated text well, but smaller models are easily distracted by irrelevant data. Hybrid retrieval is necessary to maintain precision with specialized medical terms. A structured corpus paired with a baseline hybrid pipeline offers the best stability and speed for clinical use. Conclusion Rigorous data curation and hybrid retrieval are as essential as model scale for deploying safe, guideline-compliant AI in sleep medicine.
Optimizing Microbubble Reduction to Facilitate IVUS Guidance During Endovascular Radiofrequency Wire Procedures
Plante, Curtis , Warfield, A., Escobedo, Carlos , Majdalany, David , Majdalany, Bill S. , Majdalany, David S , Majdalany, Bill S , Johri, Amer M.

Mayo Clinic

Tomography | April 2, 2026 | Volume: 12 | Issue: 4 | Pages: 48

10.3390/tomography12040048 | PMID 42042936 Get It

Background/Objectives: Radiofrequency (RF) wire energy can be used for tissue ablation across many conditions. Adjusting RF generator parameters allows RF energy to puncture tissue with minimal adjacent damage. When RF energy is applied to tissue, however, microbubbles are produced, obstructing intravascular ultrasound (IVUS). Mitigation of RF-generated microbubbles has been studied for ablation but not for puncture. Methods: This paper describes an in vitro bench study using ex vivo bovine live tissue. A model was created with bovine liver tissue and an IVUS catheter submerged in a saline bath. Tissue was punctured with an RF guidewire to recreate microbubbles. Following the puncture, various methods were applied: altering the mechanical index of the IVUS, applying a VF10-5 Linear probe (Siemens), and applying a L12-3 Linear probe (Philips). Regions of interest (ROIs) were selected to track pixel brightness as a proxy for microbubbles. Results: The control increased ROI brightness by 1.5%. Altering the mechanical index of IVUS reduced ROI brightness by 1.2%. VF10-5 probe application increased ROI brightness by 1.2%. L12-3 probe application reduced ROI brightness by 33.0% (p = 0.046, n = 3, one-sample t-test). Brightness reduction was most pronounced at the site of initial RF wire puncture, where microbubbles accumulated. Tip visualization improved, allowing for more precise wire trajectory adjustments. Conclusions: External US with an L12-3 probe was able to dissipate microbubbles effectively to improve IVUS guidance following RF wire puncture in an in vitro exploratory bench model.
Non-Typhoidal Salmonella enterica Bacteremia Complicated by Native Shoulder Septic Arthritis in a Patient with Sickle Cell Disease Following Foodborne Exposure: A Case Report and Literature Review
Godart, Gabriel A. , Yadav, Vidit , Springer, Bryan D. , Durvasula, R, Elwasila, Sammer M., Oring, Justin , Godart, Gabriel , Bestic, Joseph M. , Oring, Justin , Schoch, Bradley S. , Elwasila, Sammer M

Mayo Clinic

Infectious Disease Reports | April 2, 2026 | Volume: 18 | Issue: 2 | Pages: 30

10.3390/idr18020030 | PMID 42042319 Get It

Background/Objectives: Non-typhoidal Salmonella (NTS) species are well-recognized causes of invasive infection in patients with sickle cell disease (SCD), with a particular predilection for the musculoskeletal system. Although Salmonella osteomyelitis is well described in this population, septic arthritis is uncommon, especially involving the shoulder joint. We describe a case of NTS bacteremia complicated by native shoulder septic arthritis in a patient with SCD and review its clinical implications. Methods: We report the clinical course, diagnostic evaluation, microbiologic findings, imaging studies, and management of a 22-year-old man with homozygous SCD who presented with a vaso-occlusive pain crisis and subsequently developed severe sepsis with persistent Salmonella enterica bacteremia following ingestion of undercooked poultry. Persistent bacteremia prompted further evaluation for metastatic infection using advanced imaging and diagnostic arthrocentesis. Results: Whole-body imaging identified septic arthritis of the native right shoulder, which was confirmed by synovial fluid cultures growing Salmonella species. The patient underwent arthroscopic irrigation and debridement for source control. Antimicrobial therapy was narrowed to intravenous ceftriaxone based on susceptibility data and continued for six weeks. The patient demonstrated clinical improvement with resolution of bacteremia and was discharged to rehabilitation to complete therapy. Conclusions: This case highlights the importance of a careful exposure history, including foodborne sources, in patients with SCD presenting with invasive Salmonella infection. Persistent bacteremia should prompt early investigation for metastatic foci, and timely surgical source control combined with targeted antimicrobial therapy is essential for optimal outcomes in this population.
Efficacy of CD38 ‐Targeted Therapy in Severe, Multi‐Agent Refractory Immune Thrombocytopenia: A Case Series
Patel, Parth , Farrugia, Stefan L. , Nunnelee, Jordan , Mina, Syeda, Go, Ronald S. , Rajkumar, S. Vincent, Rajkumar, S. Vincent , Patel, Parth S , Farrugia, Stefan, Go, Ronald S , Rajkumar, S Vincent , Mina, Syeda A. , Godby, Richard

Mayo Clinic

European Journal of Haematology | April 2, 2026 | Volume: 117 | Issue: 1 | Pages: 279-282

10.1111/ejh.70180 | PMID 41923527 Get It

ABSTRACT Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by antibody‐mediated platelet destruction, often driven by long‐lived plasma cells (LLPCs) resistant to conventional therapies. While most patients respond to corticosteroids and intravenous immunoglobulin (IVIG), a subset develops life‐threatening refractory disease. In this case series, we describe three patients aged 39, 85, and 58 with life‐threatening, multi‐agent refractory ITP and platelet nadirs < 2 × 10 9 /L who failed corticosteroids, IVIG, and thrombopoietin receptor agonists (TPO‐RAs). Following salvage therapy with daratumumab, a monoclonal antibody targeting CD38, all three patients achieved rapid hematologic recovery, with platelet count normalization within 1 week. This accelerated response allowed for urgent clinical stabilization, including safe anticoagulation and surgical intervention. The efficacy of daratumumab likely stems from a dual mechanism: the depletion of CD38+ LLPCs and the immediate modulation of Fc‐receptor‐mediated platelet clearance. These observations suggest that CD38‐targeted therapy can bypass traditional treatment resistance to achieve near‐immediate remission in high‐complexity, high‐risk clinical settings. While these results are compelling, prospective clinical trials are warranted to define the long‐term safety, durability, and optimal dosing of anti‐CD38 therapies in refractory ITP populations.
Academic Value Units in Emergency Medicine: Current State and a Framework for Recognizing and Sustaining Academic Contributions
Raukar, Neha P. , Gottlieb, Michael, Miner, James R. , Chung, Arlene, Rosania, Anthony, Colletti, James E., Sule, Harsh , Chung, Arlene , Gottlieb, Michael , Miner, James , Chung, Arlene S , Gottlieb, Michael , Raukar, Neha , Rosania, Anthony R.

Mayo Clinic

AEM Education and Training | April 2, 2026 | Volume: 10 | Issue: 2 | Pages: No page available

10.1002/aet2.70149 | PMID 41938788 Get It

ABSTRACT Background Academic departments in medicine face increasing pressure to balance clinical productivity with their broader academic missions, including education, scholarship, mentorship, and service. While clinical work is routinely quantified through relative value units (RVUs), non‐clinical academic contributions are inconsistently measured and often undervalued. Academic Value Unit (AVU) systems have emerged as frameworks to quantify these activities, but adoption remains limited due to inconsistent funding models, lack of standardized frameworks, and minimal evidence demonstrating outcomes such as faculty satisfaction, retention, or return on investment (ROI). Methods This concept paper synthesizes current AVU implementation strategies in emergency medicine and proposes an evidence‐informed six‐step framework for AVU design, funding, and sustainability. The framework was informed by a literature review, analysis of institutional dashboards, and multi‐institutional input from the Society for Academic Emergency Medicine (SAEM) community, including feedback from a national didactic session at the 2025 SAEM Annual Meeting. Results The proposed framework outlines practical steps for AVU implementation: defining mission‐aligned domains, identifying measurable academic activities, establishing transparent weighting systems, integrating real‐time tracking dashboards, developing sustainable blended funding models, and engaging leadership and faculty through iterative review. The model incorporates customizable templates, adaptable activity menus, and suggested ROI metrics that departments can tailor to local institutional priorities and resources. Conclusions AVU systems offer a structured approach to recognizing and incentivizing non‐clinical academic contributions in emergency medicine. A transparent, mission‐aligned framework supported by sustainable funding and measurable ROI metrics may enhance faculty engagement, equity, and long‐term departmental sustainability. Future work should focus on establishing validated benchmarks for AVU weighting, integrating AVUs with faculty development and wellness initiatives, and evaluating longitudinal outcomes such as retention, satisfaction, and equity.
Upper Airway Anesthesia Techniques and Sedation Strategies for Awake Fiberoptic Intubation: A Novel Workshop for Anesthesia Residents
Ellis, Megan , Ivare, Hali N. , Stites, A. C., Damon, Aaron , Johnson, Jimmy A. , Huang, Jeffrey , Peterson, Hali N. , Ellis, Megan M , Stites, Andrew J , Damon, Aaron C

Mayo Clinic

MedEdPORTAL | April 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.15766/mep_2374-8265.11590 | PMID 41939796 Get It

Single-nucleus transcriptomics identifies a shared vulnerable excitatory neuronal population across typical and atypical Alzheimer’s disease
Pereira, Felipe Luiz, Lew, Caroline , Li, Song H, Paes, Vítor Ribeiro , Brooks, Sara D, Spina, Salvatore, Rexach, Jessica E, Newell, Kathy L, Leite, Renata EP, Seeley, William W, Suemoto, Claudia K, Ghetti, Bernardino, Murray, Melissa E, Grinberg, Lea T, Rizzi, Liara , Soloviev, Alexander V., Spina, Salvatore , Rexach, Jessica E. , Newell, Kathy L. , Leite, Renata Elaine Paraizo , Seeley, William W. , Suemoto, Cláudia Kimie , Ghetti, Bernardino , Murray, Melissa E. , Grinberg, Lea T.

Mayo Clinic

No container title available | April 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.30.715299 | PMID 41959086 Get It

A bstract Alzheimer’s disease (AD) presents with substantial clinical and anatomical heterogeneity, including both typical amnestic and atypical variants such as posterior cortical atrophy and logopenic primary progressive aphasia. Although neurofibrillary tangle (NFT) burden is a defining pathological feature of AD, its regional distribution varies across clinical phenotypes, suggesting that selective neuronal vulnerability may shape disease presentation. However, the cellular and molecular determinants underlying this vulnerability remain incompletely understood. Here, we profiled single-nucleus transcriptomes across multiple brain regions, including hippocampal (CA1) and neocortical (superior temporal gyrus and occipital cortex) regions, from individuals with typical and atypical AD and healthy controls. Integrative analysis identified major cell classes and resolved diverse excitatory and inhibitory neuronal subpopulations that were reproducibly observed across regions and individuals. Using quasi-binomial regression models to assess compositional changes, we quantified subtype-specific vulnerability associated with AD pathology. We identified a distinct excitatory neuronal subpopulation characterized by NRGN and BEX1 expression, which showed reproducible depletion across multiple regions, with the strongest evidence in amnestic AD and in neocortical regions in lvPPA. This vulnerable population showed concordance with previously reported AD-associated excitatory neuron signatures, supporting a conserved transcriptional program of susceptibility. Genes enriched in this population were associated with chemical synaptic transmission and regulation of synaptic plasticity and formed interconnected networks in protein-protein interaction analyses. These findings suggest that intrinsic properties related to synaptic function may predispose specific neuronal populations to degeneration in AD. Together, our results define a conserved, transcriptionally distinct excitatory neuron subpopulation that is selectively vulnerable across AD phenotypes and brain regions. This work provides a framework for linking regional pathology to cell-type-specific susceptibility and highlights synaptic regulatory pathways as potential contributors to neuronal degeneration in Alzheimer’s disease.